Ahs Cancer Control Alberta

This study tests a made-to-order cell therapy called GCAR1 in one person with advanced alveolar soft part sarcoma that has spread and has no standard treatments left. The therapy uses the patient's own immune cells, modified to recognize and attack cancer cells that carry a prote…

This study looks at adding high-dose niacin (vitamin B3) to the usual treatment for a type of aggressive brain cancer called glioblastoma. The goal is to find a safe dose and see if it helps people live longer without their cancer growing. About 59 adults with newly diagnosed gli…

This study tests whether a mobile health program can help teens and young adults who finished cancer treatment become more physically active. About 287 survivors in Alberta will either get standard educational materials or a full program including a personalized activity plan, a …